Skip to main content
Equibles

RHUMBLINE ADVISERS

Position in OKUR — OnKure Therapeutics, Inc.

CIK 1115418 BOSTON, MA
Back to OKUR Full portfolio

Position in OKUR

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$95,741
+$95,741 QoQ
Shares Held
20,996
+2035.9% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 75 holders
Holding Since
Jun 2023
6 quarters on record
Voting authority Sole 22% Shared 0% None 78%

Common Shares in OKUR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. OKUR ranks #278 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 396,380 $196,893,837
2 REGN
Regeneron Pharmaceuticals, Inc.
 157,794 $98,390,870
3 MRNA
Moderna, Inc.
 809,853 $56,714,005
4 ALNY
Alnylam Pharmaceuticals, Inc.
 165,579 $49,844,246
5 INCY
Incyte Corp
 428,533 $48,578,500
6 RVMD
Revolution Medicines, Inc.
 226,008 $42,326,778
7 ROIV
Roivant Sciences Ltd.
 1,178,789 $41,717,342
8 JAZZ
Jazz Pharmaceuticals plc
 163,018 $39,282,447

All Filings in OKUR

Export CSV
1 filing row on record
Report Date Value (USD) Shares
2026-06-30 $95,741 20,996